Meta-Analysis Assessing the Effect of Tirzepatide on the Risk for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus

被引：6
|
作者：
Patoulias, Dimitrios [1 ]
Doumas, Michael [1 ]
Papadopoulos, Christodoulos [2 ]
机构：
[1] Aristotle Univ Thessaloniki, Propaedeut Dept Internal Med 2, Gen Hosp Hippokrat, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Dept Cardiol 3, Gen Hosp Hippokrat, Thessaloniki, Greece
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2022年 / 173卷
关键词：
PREVALENCE;
D O I：
10.1016/j.amjcard.2022.03.042
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [21] Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis
    Semi Hwang
    Jung-eun Lim
    Yoonjeong Choi
    Sun Ha Jee
    BMC Endocrine Disorders, 18
  • [22] Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis
    Hwang, Semi
    Lim, Jung-eun
    Choi, Yoonjeong
    Jee, Sun Ha
    BMC ENDOCRINE DISORDERS, 2018, 18
  • [23] The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Wu, H. -D.
    Zhang, J. -J.
    Zhou, B. -J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (02): : 275 - 282
  • [24] Type 2 Diabetes Mellitus and Risk of Incident Atrial Fibrillation in Women
    Schoen, Tobias
    Pradhan, Aruna D.
    Albert, Christine M.
    Conen, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (15) : 1421 - 1428
  • [25] CARDIOMETABOLIC RISK FACTORS FOR ATRIAL FIBRILLATION IN TYPE 2 DIABETES MELLITUS
    Gaman, M.
    Dobrica, E. C.
    Pascu, E. G.
    Cozma, M. A.
    Epingeac, M. E.
    Gaman, A. M.
    Diaconu, C. C.
    JOURNAL OF HYPERTENSION, 2019, 37 : E96 - E96
  • [26] EFFECT OF SGLT-2 INHIBITORS ON THE RISK FOR ANGINA IN PATIENTS WITH OR WITHOUT TYPE 2 DIABETES MELLITUS: A META-ANALYSIS
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Toumpourleka, Maria
    Boulmpou, Aristi
    Siskos, Fotios
    Koutsampasopoulos, Konstantinos
    Petidis, Konstantinos
    Kassimis, George
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E164 - E164
  • [27] Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis
    Li, Chao
    Yu, Jie
    Hockham, Carinna
    Perkovic, Vlado
    Neuen, Brendon L.
    Badve, Sunil, V
    Houston, Lauren
    Lee, Vivian Y. J.
    Barraclough, Jennifer Y.
    Fletcher, Robert A.
    Mahaffey, Kenneth W.
    Heerspink, Hiddo J. L.
    Cannon, Christopher P.
    Neal, Bruce
    Arnott, Clare
    DIABETES OBESITY & METABOLISM, 2022, 24 (10): : 1927 - 1938
  • [28] EFFECTIVENESS OF SGLT2 INHIBITORS IN REDUCING ATRIAL FIBRILLATION RECURRENCE RISK FOLLOWING CATHETER ABLATION IN TYPE 2 DIABETES MELLITUS: A META-ANALYSIS
    Soliman, Youssef
    Abuelazm, Mohamed
    Ellabban, Mohamed
    Mouffokes, Adel
    Abdelazeem, Basel
    Saeed, Shahzeb
    Hassaballa, Hatem
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 6 - 6
  • [29] Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies
    Aune, Dagfinn
    Feng, Tingting
    Schlesinger, Sabrina
    Janszky, Imre
    Norat, Teresa
    Riboli, Elio
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (05) : 501 - 511
  • [30] The effectiveness of SGLT2 inhibitor in the incidence of atrial fibrillation/atrial flutter in patients with type 2 diabetes mellitus/ heart failure: a systematic review and meta-analysis
    Wang, Miaomiao
    Zhang, Yao
    Wang, Zhiyong
    Liu, Danliang
    Mao, Shaobin
    Liang, Bin
    JOURNAL OF THORACIC DISEASE, 2022, 14 (05) : 1620 - +
12345